SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

12 Aug 2024 Evaluate
The revenue slipped marginally during the June 2024 quarter. A decline of about Rs. 170.45 millions was observed as compared to Rs. 176.57 millions during the corresponding quarter last year.Handsome Net Profit growth of 51.82% reported above the corresponding previous quarter figure of Rs. 1.67 millions to Rs. 1.10 millions.The company reported a good operating profit of 4.51 millions compared to 3.56 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 170.45 176.57 -3.47 170.45 176.57 -3.47 672.81 653.49 2.96
Other Income 0.45 0.01 4400.00 0.45 0.01 4400.00 4.21 3.27 28.75
PBIDT 4.51 3.56 26.69 4.51 3.56 26.69 27.18 28.16 -3.48
Interest 0.21 0.23 -8.70 0.21 0.23 -8.70 0.63 0.80 -21.25
PBDT 4.30 3.33 29.13 4.30 3.33 29.13 26.55 27.36 -2.96
Depreciation 1.59 1.22 30.33 1.59 1.22 30.33 5.83 5.17 12.77
PBT 2.71 2.11 28.44 2.71 2.11 28.44 20.72 22.19 -6.62
TAX 1.04 1.01 2.97 1.04 1.01 2.97 6.12 6.96 -12.07
Deferred Tax 0.29 0.44 -34.09 0.29 0.44 -34.09 0.25 0.34 -26.47
PAT 1.67 1.10 51.82 1.67 1.10 51.82 14.60 15.23 -4.14
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 2.65 2.02 31.23 2.65 2.02 31.23 4.04 4.31 -6.25

Sandu Pharmaceutical Share Price

38.45 0.50 (1.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×